Whooping Cough and Parkinson's Disease
Identifieur interne : 001F32 ( Main/Curation ); précédent : 001F31; suivant : 001F33Whooping Cough and Parkinson's Disease
Auteurs : Jesús De Pedro-Cuesta [Espagne, Suède] ; Gretar Gudmundsson [Islande] ; Victor Abraira [Espagne] ; Gunnar Gudmundsson [Islande] ; Arthur L Ve [Islande] ; Hrafn Tulinius [Islande] ; Jorge Veiga [Espagne] ; Javier Almazán [Espagne] ; Ingolf J. Petersen [Islande]Source :
- International Journal of Epidemiology [ 0300-5771 ] ; 1996-12.
Abstract
de Pedro-Cuesta J (Instituto de Salud Carlos III, Centro Nacional de Epidemiología, Departamento de Epidemiología Aplicada, c/ Sinesio Delgado, 6, 28029 Madrid, Spain), Gudmundsson G, Abraira V, Gudmundsson G, Lōve A, Tulinius H, Veiga J, Almazán J and Petersen I J for the EUROPARKINSON Preparatory Activity Research Group. Whooping Cough and Parkinson' Disease. International Journal of Epidemiology 1996; 25: 1301–1311. Background We reported high levodopa use and prevalences of Parkinson's Disease (PD) in periodically, time-clustered, Icelandic cohorts born after major whooping cough epidemics (MWCE). Methods In order to quantify a possible relationship between age at first post-birth MWCE and risk of PD we: 1) calculated cumulative incidences of PD during the period 1954–1963 in one-year Icelandic cohorts born between 1869 and 1927, using raw material from a reported survey; 2) identified MWCE from 1869 onwards in Iceland; 3) estimated cohort ages at onset of incidence period and at first MWCE; and 4) combined the above-mentioned information using log-linear models. In addition, we studied the prevalence of levodopa users in Icelandic birth cohorts during a recent period. Results The curves of the above-mentioned incidences and prevalences in one-year birth-cohorts showed: 1) a similar, age-related, inverted V profile; and 2) a systematic notchy pattern, with peak values for one or both measurements for cohorts born during or after each of nine MWCE identified during the period 1869–1927. When 13 cohorts bom in years with MWCE were excluded from the analysis, the risk of PD rose with age at first defined MWCE, with the linear increase being 8.4% per year (95% Cl: −0.1–18.3%). Conclusions These results are consistent with reported effects of age at exposure in animal models of toxic parkinsonism, age-related changes in the dopamine receptor-GPT-binding protein-adenylatecyclase system observed in rats treated with pertussis toxin, and some PD epidemiological features. They suggest that pertussis neurotoxicity could be causally related to PD worldwide.
Url:
DOI: 10.1093/ije/25.6.1301
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002246
Links to Exploration step
ISTEX:BE91EEC02CF0EC6323722E43897EACAC369A3A6FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Whooping Cough and Parkinson's Disease</title>
<author><name sortKey="De Pedro Cuesta, Jesus" sort="De Pedro Cuesta, Jesus" uniqKey="De Pedro Cuesta J" first="Jesús" last="De Pedro-Cuesta">Jesús De Pedro-Cuesta</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Division of Neurology, Department of Clinical Neuroscience and Family Medicine, Huddinge University Hospital, Karolinska Institute Huddinge, Sweden</mods:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Neurology, Department of Clinical Neuroscience and Family Medicine, Huddinge University Hospital, Karolinska Institute Huddinge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Reprint requests: Jesús de Pedro Cuesta. Instituto de Salud Carlos III, Centro Nacional de Epidemilogía, Departmento de Epidemiología Aplicada, c/ Sinesio Delgado, 6, 28029 Madrid, Spain.</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Reprint requests: Jesús de Pedro Cuesta. Instituto de Salud Carlos III, Centro Nacional de Epidemilogía, Departmento de Epidemiología Aplicada, c/ Sinesio Delgado, 6, 28029 Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gudmundsson, Gretar" sort="Gudmundsson, Gretar" uniqKey="Gudmundsson G" first="Gretar" last="Gudmundsson">Gretar Gudmundsson</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, National University Hospital Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Department of Neurology, National University Hospital Reykjavik</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Abraira, Victor" sort="Abraira, Victor" uniqKey="Abraira V" first="Victor" last="Abraira">Victor Abraira</name>
<affiliation wicri:level="1"><mods:affiliation>Biostatistics Unit, RamÓn y Cajal Hospital, and the REUNI Centre, Carlos III Institute of Health Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Biostatistics Unit, RamÓn y Cajal Hospital, and the REUNI Centre, Carlos III Institute of Health Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gudmundsson, Gunnar" sort="Gudmundsson, Gunnar" uniqKey="Gudmundsson G" first="Gunnar" last="Gudmundsson">Gunnar Gudmundsson</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, National University Hospital Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Department of Neurology, National University Hospital Reykjavik</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="L Ve, Arthur" sort="L Ve, Arthur" uniqKey="L Ve A" first="Arthur" last="L Ve">Arthur L Ve</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Microbiology, National University Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Department of Microbiology, National University Reykjavik</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tulinius, Hrafn" sort="Tulinius, Hrafn" uniqKey="Tulinius H" first="Hrafn" last="Tulinius">Hrafn Tulinius</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Social Medicine, National University Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Department of Social Medicine, National University Reykjavik</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Veiga, Jorge" sort="Veiga, Jorge" uniqKey="Veiga J" first="Jorge" last="Veiga">Jorge Veiga</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Almazan, Javier" sort="Almazan, Javier" uniqKey="Almazan J" first="Javier" last="Almazán">Javier Almazán</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Petersen, Ingolf J" sort="Petersen, Ingolf J" uniqKey="Petersen I" first="Ingolf J" last="Petersen">Ingolf J. Petersen</name>
<affiliation wicri:level="1"><mods:affiliation>Pharmaceutical Division, Ministry of Health Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Pharmaceutical Division, Ministry of Health Reykjavik</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BE91EEC02CF0EC6323722E43897EACAC369A3A6F</idno>
<date when="1996" year="1996">1996</date>
<idno type="doi">10.1093/ije/25.6.1301</idno>
<idno type="url">https://api.istex.fr/document/BE91EEC02CF0EC6323722E43897EACAC369A3A6F/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002246</idno>
<idno type="wicri:Area/Main/Curation">001F32</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Whooping Cough and Parkinson's Disease</title>
<author><name sortKey="De Pedro Cuesta, Jesus" sort="De Pedro Cuesta, Jesus" uniqKey="De Pedro Cuesta J" first="Jesús" last="De Pedro-Cuesta">Jesús De Pedro-Cuesta</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Division of Neurology, Department of Clinical Neuroscience and Family Medicine, Huddinge University Hospital, Karolinska Institute Huddinge, Sweden</mods:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Neurology, Department of Clinical Neuroscience and Family Medicine, Huddinge University Hospital, Karolinska Institute Huddinge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Reprint requests: Jesús de Pedro Cuesta. Instituto de Salud Carlos III, Centro Nacional de Epidemilogía, Departmento de Epidemiología Aplicada, c/ Sinesio Delgado, 6, 28029 Madrid, Spain.</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Reprint requests: Jesús de Pedro Cuesta. Instituto de Salud Carlos III, Centro Nacional de Epidemilogía, Departmento de Epidemiología Aplicada, c/ Sinesio Delgado, 6, 28029 Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gudmundsson, Gretar" sort="Gudmundsson, Gretar" uniqKey="Gudmundsson G" first="Gretar" last="Gudmundsson">Gretar Gudmundsson</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, National University Hospital Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Department of Neurology, National University Hospital Reykjavik</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Abraira, Victor" sort="Abraira, Victor" uniqKey="Abraira V" first="Victor" last="Abraira">Victor Abraira</name>
<affiliation wicri:level="1"><mods:affiliation>Biostatistics Unit, RamÓn y Cajal Hospital, and the REUNI Centre, Carlos III Institute of Health Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Biostatistics Unit, RamÓn y Cajal Hospital, and the REUNI Centre, Carlos III Institute of Health Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gudmundsson, Gunnar" sort="Gudmundsson, Gunnar" uniqKey="Gudmundsson G" first="Gunnar" last="Gudmundsson">Gunnar Gudmundsson</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, National University Hospital Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Department of Neurology, National University Hospital Reykjavik</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="L Ve, Arthur" sort="L Ve, Arthur" uniqKey="L Ve A" first="Arthur" last="L Ve">Arthur L Ve</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Microbiology, National University Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Department of Microbiology, National University Reykjavik</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tulinius, Hrafn" sort="Tulinius, Hrafn" uniqKey="Tulinius H" first="Hrafn" last="Tulinius">Hrafn Tulinius</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Social Medicine, National University Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Department of Social Medicine, National University Reykjavik</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Veiga, Jorge" sort="Veiga, Jorge" uniqKey="Veiga J" first="Jorge" last="Veiga">Jorge Veiga</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Almazan, Javier" sort="Almazan, Javier" uniqKey="Almazan J" first="Javier" last="Almazán">Javier Almazán</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Petersen, Ingolf J" sort="Petersen, Ingolf J" uniqKey="Petersen I" first="Ingolf J" last="Petersen">Ingolf J. Petersen</name>
<affiliation wicri:level="1"><mods:affiliation>Pharmaceutical Division, Ministry of Health Reykjavik, Iceland</mods:affiliation>
<country xml:lang="fr">Islande</country>
<wicri:regionArea>Pharmaceutical Division, Ministry of Health Reykjavik</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">International Journal of Epidemiology</title>
<idno type="ISSN">0300-5771</idno>
<idno type="eISSN">1464-3685</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published" when="1996-12">1996-12</date>
<biblScope unit="volume">25</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1301">1301</biblScope>
<biblScope unit="page" to="1311">1311</biblScope>
</imprint>
<idno type="ISSN">0300-5771</idno>
</series>
<idno type="istex">BE91EEC02CF0EC6323722E43897EACAC369A3A6F</idno>
<idno type="DOI">10.1093/ije/25.6.1301</idno>
<idno type="ArticleID">25.6.1301</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0300-5771</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">de Pedro-Cuesta J (Instituto de Salud Carlos III, Centro Nacional de Epidemiología, Departamento de Epidemiología Aplicada, c/ Sinesio Delgado, 6, 28029 Madrid, Spain), Gudmundsson G, Abraira V, Gudmundsson G, Lōve A, Tulinius H, Veiga J, Almazán J and Petersen I J for the EUROPARKINSON Preparatory Activity Research Group. Whooping Cough and Parkinson' Disease. International Journal of Epidemiology 1996; 25: 1301–1311. Background We reported high levodopa use and prevalences of Parkinson's Disease (PD) in periodically, time-clustered, Icelandic cohorts born after major whooping cough epidemics (MWCE). Methods In order to quantify a possible relationship between age at first post-birth MWCE and risk of PD we: 1) calculated cumulative incidences of PD during the period 1954–1963 in one-year Icelandic cohorts born between 1869 and 1927, using raw material from a reported survey; 2) identified MWCE from 1869 onwards in Iceland; 3) estimated cohort ages at onset of incidence period and at first MWCE; and 4) combined the above-mentioned information using log-linear models. In addition, we studied the prevalence of levodopa users in Icelandic birth cohorts during a recent period. Results The curves of the above-mentioned incidences and prevalences in one-year birth-cohorts showed: 1) a similar, age-related, inverted V profile; and 2) a systematic notchy pattern, with peak values for one or both measurements for cohorts born during or after each of nine MWCE identified during the period 1869–1927. When 13 cohorts bom in years with MWCE were excluded from the analysis, the risk of PD rose with age at first defined MWCE, with the linear increase being 8.4% per year (95% Cl: −0.1–18.3%). Conclusions These results are consistent with reported effects of age at exposure in animal models of toxic parkinsonism, age-related changes in the dopamine receptor-GPT-binding protein-adenylatecyclase system observed in rats treated with pertussis toxin, and some PD epidemiological features. They suggest that pertussis neurotoxicity could be causally related to PD worldwide.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001F32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:BE91EEC02CF0EC6323722E43897EACAC369A3A6F |texte= Whooping Cough and Parkinson's Disease }}
This area was generated with Dilib version V0.6.23. |